Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Deficient adaptation to centrosome duplication defects in neural progenitors causes microcephaly and subcortical heterotopias
José González-Martínez, Andrzej W. Cwetsch, Diego Martínez-Alonso, Luis R. López-Sainz, Jorge Almagro, Anna Melati, Jesús Gómez, Manuel Pérez-Martínez, Diego Megías, Jasminka Boskovic, Javier Gilabert-Juan, Osvaldo Graña-Castro, Alessandra Pierani, Axel Behrens, Sagrario Ortega, Marcos Malumbres
José González-Martínez, Andrzej W. Cwetsch, Diego Martínez-Alonso, Luis R. López-Sainz, Jorge Almagro, Anna Melati, Jesús Gómez, Manuel Pérez-Martínez, Diego Megías, Jasminka Boskovic, Javier Gilabert-Juan, Osvaldo Graña-Castro, Alessandra Pierani, Axel Behrens, Sagrario Ortega, Marcos Malumbres
View: Text | PDF
Research Article Cell biology Development

Deficient adaptation to centrosome duplication defects in neural progenitors causes microcephaly and subcortical heterotopias

  • Text
  • PDF
Abstract

Congenital microcephaly (MCPH) is a neurodevelopmental disease associated with mutations in genes encoding proteins involved in centrosomal and chromosomal dynamics during mitosis. Detailed MCPH pathogenesis at the cellular level is still elusive, given the diversity of MCPH genes and lack of comparative in vivo studies. By generating a series of CRISPR/Cas9-mediated genetic KOs, we report here that — whereas defects in spindle pole proteins (ASPM, MCPH5) result in mild MCPH during development — lack of centrosome (CDK5RAP2, MCPH3) or centriole (CEP135, MCPH8) regulators induces delayed chromosome segregation and chromosomal instability in neural progenitors (NPs). Our mouse model of MCPH8 suggests that loss of CEP135 results in centriole duplication defects, TP53 activation, and cell death of NPs. Trp53 ablation in a Cep135-deficient background prevents cell death but not MCPH, and it leads to subcortical heterotopias, a malformation seen in MCPH8 patients. These results suggest that MCPH in some MCPH patients can arise from the lack of adaptation to centriole defects in NPs and may lead to architectural defects if chromosomally unstable cells are not eliminated during brain development.

Authors

José González-Martínez, Andrzej W. Cwetsch, Diego Martínez-Alonso, Luis R. López-Sainz, Jorge Almagro, Anna Melati, Jesús Gómez, Manuel Pérez-Martínez, Diego Megías, Jasminka Boskovic, Javier Gilabert-Juan, Osvaldo Graña-Castro, Alessandra Pierani, Axel Behrens, Sagrario Ortega, Marcos Malumbres

×

Figure 2

Centrosome dynamics defects in Cep135-deficient fibroblasts.

Options: View larger image (or click on image) Download as PowerPoint
Centrosome dynamics defects in Cep135-deficient fibroblasts.
(A) Confoca...
(A) Confocal imaging of E14.5 Cep135-mutant and control MEFs stained with the indicated markers. The histogram shows the percentage of cells with 1, 2, or more than 2 γ-tubulin spots. (B) Immunostaining of MEFs with the indicated markers. The bottom histograms show the percentage of cyclin A+ cells with 1, 2, or more than 2 γ-tubulin spots in the different phases of the cell cycle, as determined by PCNA and PH3 staining. (C) Immunostaining with antibodies against centrin (green), γ-tubulin (red), and ODF2 (cenexin, a marker of the mother centrosome; gray), and quantification of γ-tubulin mean fluorescence intensity (MFI). Slashed lines link 2 centrosomes from the same cell; higher slope of the line indicates higher centrosomal asymmetry. (D) Confocal imaging of E14.5 Cep135(Δ8/Δ8) MEFs. All cells depicted are cyclin A+. Group I: 2 γ-tubulin spots; 2 centrin doublets. Group II: 2 γ-tubulin spots; 2 centrin singlets. Group III: 2 γ-tubulin spots; 1 centrin doublet + 1 centrin singlet. Group IV: 2 γ-tubulin spots; 1 centrin doublet + 1 centrin singlet. Group V: 1 γ-tubulin spot; 1 centrin doublet. Group VI: 1 γ-tubulin spot; 1 centrin singlet. Group VII: acentrosomal. Group VIII: >2 γ-tubulin spots. (E) As in D. Group I: 2 γ-tubulin spots; 2 Sas6 singlets. Group II: 2 γ-tubulin spots; 1 Sas6 singlet + no Sas6. Group III: 2 γ-tubulin spots; no Sas6 – no Sas6. Group IV: 1 γ-tubulin spot; 1 Sas6 singlet. Group V: 1 γ-tubulin spot; no Sas6. (F) Confocal imaging of E14.5 MEFs and percentage of cyclin A+ cells with 1 or 2 γ-tubulin spots. Scale bars: 10 μm (A–F). Data are mean ± SEM from 3 cultures from 3 E14.5 embryos; n > 150 cells/condition; **P < 0.01; ***P < 0.001; 1-way ANOVA with Tukey’s multiple comparisons (A, B, and F) and Student’s t test (C–E).

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts